Israel Englander 2seventy Bio, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 153,557 shares of TSVT stock, worth $477,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares

153,557

Previous 475,085 67.68%

Holding current value

$477,562

Previous $1.83 Million 60.42%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.85 - $5.05 $1.24 Million - $1.62 Million	-321,528 Reduced 67.68%	153,557 $724,000
Q2 2024 Aug 14, 2024	SELL	$3.6 - $5.79 $721,252 - $1.16 Million	-200,348 Reduced 29.66%	475,085 $1.83 Million
Q1 2024 May 15, 2024	SELL	$3.09 - $6.0 $5.13 Million - $9.96 Million	-1,659,839 Reduced 71.08%	675,433 $3.61 Million
Q4 2023 Feb 14, 2024	SELL	$1.57 - $4.58 $879,520 - $2.57 Million	-560,204 Reduced 19.35%	2,335,272 $9.97 Million
Q2 2023 Aug 14, 2023	BUY	$8.45 - $12.48 $8.05 Million - $11.9 Million	952,858 Added 49.05%	2,895,476 $29.3 Million
Q1 2023 May 15, 2023	BUY	$9.21 - $14.98 $5.32 Million - $8.65 Million	577,227 Added 42.28%	1,942,618 $19.8 Million
Q4 2022 Feb 14, 2023	BUY	$8.57 - $17.0 $5.13 Million - $10.2 Million	598,734 Added 78.1%	1,365,391 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $2.94 Million - $4.1 Million	233,786 Added 43.87%	766,657 $11.2 Million

Others Institutions Holding TSVT

# of Institutions

126

Shares Held

45.6M

Call Options Held

122K

Put Options Held

19.8K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $118M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account